KPC Pharmaceuticals Inc Capital Reinvestment Ratio
KPC Pharmaceuticals Inc capital reinvestment ratio. KPC Pharmaceuticals Inc (600422) has a Capital Reinvestment Ratio of 0.29x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥113.07 Million) in capital expenditures (CN¥32.53 Million). Check how aggressively does KPC Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of KPC Pharmaceuticals Inc (1999–2025)
Capital reinvestment ratio of KPC Pharmaceuticals Inc from 1999 to 2025. This chart tracks KPC Pharmaceuticals Inc's Capital Reinvestment Ratio across 25 annual periods. Also explore KPC Pharmaceuticals Inc (600422) net asset momentum to track the company's year-over-year net asset growth rate.
KPC Pharmaceuticals Inc Capital Reinvestment Ratio by Year (1999–2025)
KPC Pharmaceuticals Inc capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see KPC Pharmaceuticals Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥289.24 Million | CN¥90.56 Million | ▲ +218.5% |
| 2024 | 0.10x | CN¥808.07 Million | CN¥79.43 Million | ▼ -32.4% |
| 2023 | 0.15x | CN¥754.33 Million | CN¥109.64 Million | ▼ -63.7% |
| 2022 | 0.40x | CN¥253.90 Million | CN¥101.75 Million | ▼ -57.3% |
| 2021 | 0.94x | CN¥251.63 Million | CN¥236.17 Million | ▲ +142.4% |
| 2020 | 0.39x | CN¥409.94 Million | CN¥158.73 Million | ▼ -52.1% |
| 2019 | 0.81x | CN¥429.50 Million | CN¥347.35 Million | ▲ +31.1% |
| 2018 | 0.62x | CN¥352.07 Million | CN¥217.26 Million | ▼ -44.3% |
| 2017 | 1.11x | CN¥242.53 Million | CN¥268.74 Million | ▲ +69.5% |
| 2016 | 0.65x | CN¥311.16 Million | CN¥203.45 Million | ▲ +47.8% |
| 2015 | 0.44x | CN¥476.62 Million | CN¥210.82 Million | ▼ -24.8% |
| 2014 | 0.59x | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥60.24 Million | CN¥12.67 Million | — |